Kevin Hrusovsky Email and Phone Number
Kevin Hrusovsky work email
- Valid
- Valid
- Valid
- Valid
- Valid
Kevin Hrusovsky personal email
- Valid
- Valid
- Valid
Kevin Hrusovsky phone numbers
A biotech entrepreneur and healthcare visionary helping transform medicine from reactive “sick care” to preventative healthcare, catalyzing a precision health movement promoting innovation for eradicating disease and personalizing health. Founded Powering Precision Health foundation, advancing the science of personalized precision health (PPH). Hrusovsky is the 2018 New England EY Entrepreneur of the Year®, and received Lifetime Achievement Award for Leadership, the BBJ Innovation Allstar award, the Ohio State Univ E.G. Bailey Entrepreneurship Award (2013) and an honorary doctorate from FSU for healthcare innovation. A dynamic speaker, often invited to present at leading conferences & symposiums.He is Chairman of 908 Devices, a co democratizing mass spectrometry, serves on the BoD of DA32 and is chairman of PPH. In 2022, he retired as chairman and ceo of Quanterix - QTRX. During his 7 yr tenure, grew revenue from < $5m to over $110m, ipo’ed in 2017 (raised $800m in private & public offerings - all up rounds), launched numerous innovations enabling pre-symptomatic non-invasive (blood) detection of Alzheimer’s, neurodegenerative disease and covid and as well as similar advances for cancer and heart disease. Thru summits, helped to inspire nearly 2k third party peer reviewed pubs validating these advances. Hrusovsky has strong track record for disruptive innovation, growing highly inspired companies, executing “game-changing” strategies and delivering strong investor returns (private & public). He has led or served on these co BoD’s: Quanterix - QTRX, Caliper - CALP (sold to PKI), Xenogen - XGEN (sold to CALP), BioIVT (sold to Linden), SeraCare - SERA ( sold to Linden), Zymark (sold to CALP). He also ran PKI Life Sciences & Tech, FMC Pharma & AG Chem Int’l and DuPont Viton and NA Teflon. Hrusovsky holds an M.B.A. from Ohio University and a B.S. in Mechanical Engineering from The Ohio State University.
-
Other Board Of Director AssignmentsList BelowBoston, Ma, Us
-
Chairman Of The Board Of Directors908 Devices 2013 - PresentBoston, Massachusetts, UsDisruptive hand-held mass spectrometer company
-
Founder & ChairmanPowering Precision Health Jan 2014 - PresentBoston, Ma, UsPowering Precision Health aims to establish a new paradigm for healthy living by fostering collaboration amongst the world’s foremost doctors, researchers, scientists, innovators, investors and policymakers who together work to transform healthcare. -
Board MemberDa32 Life Science Tech 2021 - PresentDA32 Life Science Tech is a Special Purpose Acquisition Corp (SPAC) dedicated to funding, building and catalyzing the most promising opportunities in life science tech.
-
Other Board Of Director AssignmentsList Below 1999 - PresentBrown University Biomedical BOD, Boston Children Hospital Strategy BOD, Massachusetts Biotech Council Curriculum BOD, Association for Lab Automation (ALA) BOD, Hopkinton Country Club BOD,School BOD Superintendent Search Committee
-
Chairman & CeoQuanterix Mar 2015 - Aug 2022Billerica, Massachusetts, UsChairman of the Board: 3/15 - 8/22Ceo: 9/15 - 4/22Total raised $800million - all up rounds. Several private and crossover raises, IPO Dec’17 - 7x oversubscribed and three productive up round follow on raises.Revenue increased from <$5m to $110m - cagr 50%+Restored diagnostic rights and secured major collaborations with Abbott Labs, Siemens, BioMerioux, Lilly, NIH, UnitedHealth Group, Pfizer, Roche, Novartis, J&J, Amgen, LabCorp, Quest, Mayo Clinic and many other pharma, biotech and Dx co’s. Launched numerous disruptive products making major advances into minimum invasive (blood testing) early detection of Alzheimer’s, MS, Parkinson, concussion, infectious disease, heart disease and cancer for early disease detection, patient stratification, drug dev’l, trial recruitment, drug targeting and MRD management. Helped catalyze, utilizing summits and think tanks, numerous collaborations and nearly 2000 third party peer reviewed publications. Dedicated to strong relationships, communication and inspired culture with all key constituencies, ie, patient advocates, payors, agencies, employees, partners, customers & investors. -
Executive Chairman Of The BoardQuanterix Jun 2014 - Aug 2022Billerica, Massachusetts, Us
-
Board MemberBioivt 2016 - 2021Hicksville, Ny, UsBioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. -
Member Of The Board Of DirectorsSolect Energy Development, Llc Jul 2013 - Feb 2018Hopkinton, Ma, Us -
Member Of The Board Of DirectorsSynapdx Oct 2013 - May 2017
-
President, Life Sciences & TechnologyPerkinelmer Nov 2011 - Sep 2013Shelton, Ct, UsServed as Senior Vice President and President, Life Sciences and Technology and an officer of PerkinElmer as of February 2012. Informatics and Services added to responsibilities in Oct'12. Revenue responsibility $750m. Laid out roadmap to integrate acquired companies, simplify the footprint and build a center for personalized health innovations. Defined strategy to evolve PKI into a leader within the rapidly evolving field of personalized medicine and wellness. -
Member Of The Board Of DirectorsSeracare Life Sciences Srls 2010 - 2012Milford, Ma, UsRan successful auction - Sold to Linden Partners -
Ceo, President And DirectorCaliper Life Sciences Sep 2003 - Oct 2011Sold CALP to PKI for $650m cash in Nov'11. CALP's stock appreciated 1000% in the three-year period from 2009-2011, making it the fastest appreciating stock in the entire life sciences landscape. CALP became known as the Apple of Life Science tools with its extremely innovative products, technologies and customer / market-centric culture / strategy that disrupted the genomics and proteomics fields with precise, automated imaging, microfluidics and experimentation platforms. Prior to CALP, Kevin was President and CEO of Zymark Corporation. In this role, which Kevin assumed in 1996, Zymark acquired several companies before merging with Caliper Tech in July 2003. Kevin was appointed CEO and President of Caliper Tech at that time, renaming the company Caliper Life Sciences. Under his leadership, CALP acquired three more companies (one public XGEN and two private) and divested four businesses to evolve into the leading personalized medicine / wellness company. Rapid progress was achieved in commercializing LabChip(R) technologies and whole animal, tissue and circulating tumor cell imaging camera technologies over the six-year period. Achieved double digit top line growth during recession, distancing itself from other companies in the field. Evolved technologies from research markets into clinical markets. -
Member Of The Board Of DirectorsXenogen Corporation 2004 - 2006UsBuilt value and acquired into CALP -
Ceo And PresidentZymark Limited 1996 - 2003
-
Member Of The Board Of DirectorsAlliant Medical Technology, Formerly Euromed 2000 - 2002
-
International General Manager Ag ChemicalsFmc 1995 - 1996Philadelphia , Pennsylvania, Us -
Division Manager Pharmaceutical BusinessFmc 1992 - 1995Philadelphia , Pennsylvania, Us
-
Business Manager TeflonDupont 1991 - 1992Wilmington, De, Us -
Business Manager VitonDupont 1988 - 1991Wilmington, De, Us
-
Manufacturing Manager Engineering PlasticsDupont 1987 - 1988Wilmington, De, Us
-
Production Manager Zytel NylonDupont 1986 - 1987Wilmington, De, Us
-
Program Manager Textile Fiber - Engineering PlasticsDupont 1985 - 1986Wilmington, De, Us
-
Production Manager Hydrogen PeroxideDupont Sep 1984 - Jul 1985Wilmington, De, Us
-
Production Superintendent Solid PeroxygensDupont Sep 1983 - Sep 1984Wilmington, De, Us
-
R&D Peroxygen ProductsDupont Jun 1983 - Sep 1983Wilmington, De, Us
Kevin Hrusovsky Skills
Kevin Hrusovsky Education Details
-
The Ohio State UniversityMechanical Engineering -
Harvard UniversityNine Month Building Competitive Strategy Curriculum
-
Ohio UniversityMarketing/Finance
Frequently Asked Questions about Kevin Hrusovsky
What company does Kevin Hrusovsky work for?
Kevin Hrusovsky works for List Below
What is Kevin Hrusovsky's role at the current company?
Kevin Hrusovsky's current role is Other Board of Director Assignments.
What is Kevin Hrusovsky's email address?
Kevin Hrusovsky's email address is kh****@****rix.com
What is Kevin Hrusovsky's direct phone number?
Kevin Hrusovsky's direct phone number is +150854*****
What schools did Kevin Hrusovsky attend?
Kevin Hrusovsky attended The Ohio State University, Harvard University, Ohio University.
What are some of Kevin Hrusovsky's interests?
Kevin Hrusovsky has interest in Bc Eagles And U Of Delaware Blue Hens, Buckeyes.
What skills is Kevin Hrusovsky known for?
Kevin Hrusovsky has skills like Biotechnology, Lifesciences, Drug Discovery, R&d, Commercialization, Pharmaceutical Industry, Life Sciences, Strategy, Medical Devices, Strategic Planning, Genomics, Cross Functional Team Leadership.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial